Cargando…

Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia

BACKGROUND: Carbapenem-Resistant Gram-Negative (CRGN) Bloodstream Infections (BSI) represent a therapeutic challenge, especially in the context of Febrile Neutropenia (FN) in cancer patients. METHODS: We characterized pathogens causing BSI in patients aged ≥18 years who had undergone systemic chemot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schonardie, Ana Paula, Beck, Eduarda, Rigatto, Maria Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024133/ https://www.ncbi.nlm.nih.gov/pubmed/36809849 http://dx.doi.org/10.1016/j.bjid.2023.102758

Ejemplares similares

A Dynamic Approach for Early Risk Prediction of Gram-Negative Bloodstream Infection and Systemic Inflammatory Response Syndrome in Febrile Pediatric Hemato-Oncology Patients
por: Villegas Rubio, José Antonio, et al.
Publicado: (2022)

Catheter-related bloodstream infections in hemato-oncology paediatric patients
por: Giamberardino, HIG, et al.
Publicado: (2015)

Bloodstream infection in pediatric patients with febrile neutropenia induced by chemotherapy
por: Lima, Mariana Antunes Faria, et al.
Publicado: (2023)

Does Fever Response to Acetaminophen Predict Bloodstream Infections in Febrile Neutropenia?
por: Mackie, Duncan B, et al.
Publicado: (2023)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

186. Evaluating Clinical Outcomes for Treatment of Staphylococcal Bloodstream Infection in Patients with Febrile Neutropenia
por: Aleissa, Muneerah M, et al.
Publicado: (2021)

Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay
por: Kousouli, E., et al.
Publicado: (2019)

All-Cause Mortality and Its Predictors in Haemato-Oncology Patients with Febrile Neutropenia
por: Shmuely, Haim, et al.
Publicado: (2023)

Clinical Characteristics and Outcome of Bloodstream Infections in HIV-Infected Patients with Cancer and Febrile Neutropenia: A Case–Control Study
por: Puerta-Alcalde, Pedro, et al.
Publicado: (2021)

1016. Bloodstream Infection Survey in High-Risk Oncology Patients (BISHOP) With Fever and Neutropenia (FN): Predictors for Morbidity and Mortality
por: Freifeld, Alison G, et al.
Publicado: (2018)

Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study
por: Wang, Ling, et al.
Publicado: (2015)

Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia
por: Haeusler, Gabrielle M, et al.
Publicado: (2020)

Secondary Infections in Cancer Patients with Febrile Neutropenia
por: Azap, Alpay, et al.
Publicado: (2012)

Stem Cells in Hemato-Oncology
por: Damodar, S
Publicado: (2006)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021)

1841. Incidence and Predictors of Complications in Gram Negative Bloodstream Infection
por: Mondal, Utpal, et al.
Publicado: (2022)

1191. Prevalence and Microbiology of Carbapenem Resistance Among Six Gram-Negative Pathogens in Bloodstream Infections in US Hospitals, 2010–2015
por: Lodise, Thomas P, et al.
Publicado: (2018)

Investigation of seasonal frequency and pathogens in febrile neutropenia
por: Özdemir, Seray Karagöz, et al.
Publicado: (2019)

Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014)

Nosocomial bloodstream infection and the emerging carbapenem-resistant pathogen Ralstonia insidiosa
por: Fang, Qingqing, et al.
Publicado: (2019)

Evaluation of Asymptomatic Covid Infection in Children with Pediatric Hemato-Oncologic Disease
por: Bahadir, Aysenur, et al.
Publicado: (2022)

Evaluation of Bloodstream Infections During Chemotherapy-Induced Febrile Neutropenia in Patients with Malignant Hematological Diseases: Single Center Experience
por: Piukovics, Klára, et al.
Publicado: (2015)

The application of nanopore targeted sequencing in the diagnosis and antimicrobial treatment guidance of bloodstream infection of febrile neutropenia patients with hematologic disease
por: Hong, Mei, et al.
Publicado: (2023)

Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii-calcoaceticus Complex
por: Garcia, Rebeca Carvalho Lacerda, et al.
Publicado: (2023)

Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
por: Cennamo, Federica, et al.
Publicado: (2021)

The Relationship Between Antibiotic Agent and Mortality in Patients With Febrile Neutropenia due to Staphylococcal Bloodstream Infection: A Multicenter Cohort Study
por: Aleissa, Muneerah M, et al.
Publicado: (2022)

IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients
por: Vallejo, Carlos, et al.
Publicado: (2023)

The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia
por: Jungrungrueng, Thanyathorn, et al.
Publicado: (2021)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

2163. Risk Factors for Carbapenem-Resistant Gram-Negative Bloodstream Infections (BSI) in U.S. Hospitals (2010–2015)
por: Cai, Bin, et al.
Publicado: (2018)

Bacterial infection profiles in lung cancer patients with febrile neutropenia
por: Lanoix, Jean-Philippe, et al.
Publicado: (2011)

SARS-CoV-2 infection in children with febrile neutropenia
por: Flores, Victoria, et al.
Publicado: (2020)

Gemella Haemolysans Infective Endocarditis in a Patient With Febrile Neutropenia
por: Eslinger, Logan J, et al.
Publicado: (2022)

Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations
por: Tohamy, Sally Tohamy, et al.
Publicado: (2018)

Predictors of Outcome and Severity in Adult Filipino Patients with Febrile Neutropenia
por: Yu, Marc Gregory Y., et al.
Publicado: (2015)

Predictors of outcome and severity in adult filipino patients with febrile neutropenia
por: Villalobos, REM, et al.
Publicado: (2015)

Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
por: Rivera-Villegas, Hector Orlando, et al.
Publicado: (2023)

PRES in the course of hemato-oncological treatment in children
por: Musioł, Katarzyna, et al.
Publicado: (2017)

Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients
por: Caldwell, Louise, et al.
Publicado: (2022)

Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients
por: Ko, Jae-Hoon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1g6nmnh7s7irpfce0pa7utr5a4